Alimera Sciences, Inc.
ALIM · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $11 | $14 | $12 | $8 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $37 | $34 | $35 | $34 |
| Inventory | $3 | $2 | $2 | $2 |
| Other Curr. Assets | $4 | $4 | $4 | $4 |
| Total Curr. Assets | $55 | $54 | $52 | $48 |
| Property Plant & Equip (Net) | $3 | $3 | $4 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $92 | $94 | $97 | $102 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $95 | $98 | $101 | $106 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $150 | $152 | $154 | $154 |
| Liabilities | – | – | – | – |
| Payables | $10 | $10 | $8 | $6 |
| Short-Term Debt | $0 | $0 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $9 | $10 | $13 | $11 |
| Total Curr. Liab. | $20 | $21 | $22 | $18 |
| LT Debt | $70 | $69 | $64 | $64 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $22 | $22 | $21 | $23 |
| Total NC Liab. | $92 | $91 | $85 | $88 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $1 | $0 |
| Total Liabilities | $112 | $112 | $107 | $105 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $4 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$428 | -$425 | -$418 | -$415 |
| AOCI | $1 | $2 | $2 | -$3 |
| Other Equity | $465 | $468 | $467 | $466 |
| Total Equity | $39 | $41 | $46 | $49 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $150 | $152 | $154 | $154 |
| Net Debt | $59 | $55 | $53 | $56 |